Brendan Hannah

Brendan Hannah

No más puestos en curso

Fortuna: 56 097 $ al 30/09/2026

41 años
Health Technology
Consumer Services
Commercial Services

Perfil

Mr. Brendan Hannah was previously employed as a COO, Chief Business & Compliance Officer by Quince Therapeutics, Inc., a Chief Operating Officer by Novosteo, Inc., a Chief Business Officer by Neuroptika, Inc., a Head-Corporate Development by Agenovir Corp., a Vice President-Operations & Strategy by Geom Therapeutics, Inc., and a Director-Business Development by Cidara Therapeutics, Inc. He received his undergraduate degree from The Colorado College and an MBA from Anderson School of Management.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
29/07/2026 1.809 ( 0,02 % ) 56 097 $ 30/09/2026

Antiguos cargos conocidos de Brendan Hannah.

EmpresasCargoFin
IRULYA THERAPEUTICS INC. Director Financiero/CFO 08/10/2026
Director de Operaciones 01/05/2022
Corporate Officer/Principal 01/10/2021
Corporate Officer/Principal 01/03/2020
Corporate Officer/Principal 01/01/2018
Ver el detalle de la experiencia de Brendan Hannah.

Formación de Brendan Hannah.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

27

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology